CORV News and Press, Correvio Pharma Corp.

NASDAQ: CORV TSX: CORV VANCOUVER , May 21, 2020 /PRNewswire/ - Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order...

Merger activity sputtered to a stop again last week with no new deals announced and one deal closing. This is the fifth week this year with no new deals announced. There were however some potential deals that were announced last week. On Monday, May 11, 2020, according to Bloomberg, Amazon.c...

Correvio Announces Results from Annual General and Special Meeting of Securityholders Canada NewsWire VANCOUVER, May 15, 2020 Securityholders Approve ADVANZ PHARMA Acquisition NASDAQ: CORV   TSX: CORV VANCOUVER , May 15, 2020 /CNW/ - Correvio Pharma Cor...

NASDAQ: CORV   TSX: CORV VANCOUVER , May 6, 2020 /PRNewswire/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, released a report...

Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19 Canada NewsWire VANCOUVER, May 4, 2020 NASDAQ: CORV   TSX: CORV VANCOUVER , May 4, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") ...

NASDAQ: CORV   TSX: CORV VANCOUVER , May 1, 2020 /PRNewswire/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, released a re...

NEW YORK , April 20, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the...

NASDAQ: CORV   TSX: CORV VANCOUVER , April 8, 2020 /PRNewswire/ - Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced  that it has obt...

Correvio Pharma (NASDAQ: CORV ): FY GAAP EPS of -$0.79 misses by $0.01 . More news on: Correvio Pharma Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...

Correvio Reports Full Year 2019 Financial Results Canada NewsWire VANCOUVER, March 30, 2020 ADVANZ PHARMA to Acquire Correvio in a Deal Valued at US$76 Million Correvio to Hold a Meeting of Its Securityholders by No Later than May 20, 2020 Transaction Expected t...